ABI

59.68

0%↓

CDI

441

+0.36%↑

DG

128

+1.15%↑

AD

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

DG

128

+1.15%↑

AD

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

DG

128

+1.15%↑

AD

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

DG

128

+1.15%↑

AD

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

DG

128

+1.15%↑

AD

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

Search

Fluidra SA

Закрыт

СекторПотребительские товары
(защитный сектор)

19.94 -0.7

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

19.7

Макс.

20.12

Ключевые показатели

By Trading Economics

Доход

-9.6M

17M

Продажи

-38M

460M

P/E

Средняя по отрасли

20.968

27.787

Прибыль на акцию

0.19

Дивидендная доходность

3.46

Рентабельность продаж

3.775

Сотрудники

6,767

EBITDA

365M

460M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+34.08% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

3.46%

3.82%

Следующий отчет о доходах

6 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-862M

3.7B

Предыдущая цена открытия

20.64

Предыдущая цена закрытия

19.94

Новостные настроения

By Acuity

29%

71%

29 / 131 Рейтинг в Consumer defensive

Техническая оценка

By Trading Central

Уверенность

Bearish Evidence

Fluidra SA График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

31 мар. 2026 г., 23:31 UTC

Популярные акции

Stocks to Watch: Nike, RH, NCino

31 мар. 2026 г., 22:35 UTC

Отчет

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 апр. 2026 г., 00:00 UTC

Приобретения, слияния, поглощения

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 мар. 2026 г., 23:50 UTC

Приобретения, слияния, поглощения

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 мар. 2026 г., 23:43 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 мар. 2026 г., 23:33 UTC

Обсуждения рынка
Главные новостные события

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 мар. 2026 г., 23:21 UTC

Отчет

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 мар. 2026 г., 23:14 UTC

Обсуждения рынка
Отчет

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 мар. 2026 г., 23:12 UTC

Обсуждения рынка

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Loss Widens >000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 мар. 2026 г., 21:46 UTC

Приобретения, слияния, поглощения

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 мар. 2026 г., 21:36 UTC

Обсуждения рынка

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 мар. 2026 г., 21:33 UTC

Отчет

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 мар. 2026 г., 21:32 UTC

Отчет

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 мар. 2026 г., 21:28 UTC

Отчет

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 мар. 2026 г., 21:26 UTC

Отчет

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 мар. 2026 г., 21:25 UTC

Отчет

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 мар. 2026 г., 21:24 UTC

Обсуждения рынка
Отчет

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 мар. 2026 г., 21:22 UTC

Отчет

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 мар. 2026 г., 21:22 UTC

Отчет

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 мар. 2026 г., 21:21 UTC

Отчет

Nike's Digital Channel Still Too Promotional, CFO Says

31 мар. 2026 г., 21:20 UTC

Отчет

Nike CEO: Converse Remains Important to Portfolio

Сравнение c конкурентами

Изменение цены

Fluidra SA Прогноз

Целевая цена

By TipRanks

34.08% рост

Прогноз на 12 месяцев

Средняя 26.87 EUR  34.08%

Максимум 31 EUR

Минимум 21.5 EUR

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Fluidra SA на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

6 ratings

4

Покупка

1

Удержание

1

Продажа

Техническая оценка

By Trading Central

20.12 / 20.22Поддержка и Сопротивление

Краткосрочная

Bearish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Strong Bearish Evidence

Настроения

By Acuity

29 / 131Рейтинг в Потребительские товары<br>(защитный сектор)

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Fluidra SA

Fluidra, S.A., together with its subsidiaries, manufactures, distributes, and markets accessories and machinery for swimming-pools, irrigation and water treatment, and purification for residential and commercial pool market worldwide. The company provides basic pool fittings, which includes ladders, showers, pumps, valves, filters, heaters, grilles, water lighting, cleaning accessories, and others; robotic pool cleaners, pool covers, fire and water features, slides, springboards, and connected products; pool fittings spare parts; above-ground pools, and natural ponds and pools; and swim spas, saunas and steam baths, sensory showers, and Nordic baths. It also provides commercial pool and wellness water facilities for public use, including hotel and resort pools, water parks, municipal and competition pools, spa and wellness centers, fountains, lagoons, and aquariums; and develops turnkey aquatic projects. In addition, the company offers pool water treatment products; irrigation accessories for gardens; and manufactures and distributes high-end valves and accessories to build pool hydraulic circuits. It sells its products under the Astral Pool, Zodiac, Jandy, Polaris, GRE, Cepex, CTX Professional, Certikin, and Piscine Laghetto brands. The company was formerly known as Aquaria de Inv. Corp., S.L. and changed its name to Fluidra, S.A. in September 2007. Fluidra, S.A. was founded in 1969 and is headquartered in Sant Cugat del Vallès, Spain.
help-icon Live chat